H eart failure (HF) is characterized by systolic and diastolic dysfunction and abnormalities of intracellular Ca 2+ handling with disturbed excitation-contraction coupling underlying contractile failure. 1 Current research focuses on better understanding the mechanisms that lead to disturbed Ca 2+ handling during progression from cardiac remodeling (such as hypertrophy) to failure.
[Ca 2+ ] nuc is the nuclear envelope (NE), which not only contributes to nuclear structure and insulation from the surrounding cytoplasm but also controls bidirectional transport of ions (including Ca 2+ ) and macromolecular cargo via nuclear pore complexes (NPCs). The NE is also a functional Ca 2+ store, akin to the sarcoplasmic reticulum (SR), and contains Ca 2+ pumps (SR Ca 2+ -ATPase 2 [SERCA2]) and Ca 2+ release channels. The regulation of [Ca 2+ ] nuc via Ca 2+ release from the NE is also important in Ca 2+ -mediated gene expression. 9, 10 However, it remains unknown whether specific alterations in NE and nuclear Ca 2+ handling occur in cardiac disease.
Therefore, we analyzed NE structure and function during cardiac remodeling from hypertrophy to HF in animal models of pressure overload and in nonfailing and failing human hearts. We demonstrate that NE structure, its molecular composition, and nucleoplasmic CaTs undergo significant changes during pressure overload-induced hypertrophy in experimental animal models and in failing human hearts. These nuclear changes precede the changes in cytoplasmic Ca 2+ dysregulation and thus suggest that altered nucleoplasmic [Ca 2+ ] is an early event during remodeling and may contribute to the development and progression of cardiac hypertrophy and failure via nuclear Ca 2+ -dependent regulation of gene expression through activation of nuclear Ca 2+ /calmodulindependent protein kinase II (CaMKII) and nuclear export of histone deacetylases (HDAC). Normalization of impaired [Ca 2+ ] nuc regulation may therefore represent a novel therapeutic target to prevent adverse cardiac remodeling.
Methods
A detailed description of the methods used in the present study can be found in the online-only Data Supplement.
Animal Models
All experimental procedures involving animals were approved by the local animal care and use committees according to the Guide for the Care and Use of Laboratory Animals prepared by the US National Academy of Sciences (National Institutes of Health publication No. 85-23, revised 1996) . Hypertrophy and HF were induced by transverse aortic constriction (TAC) in C57BL/6 mice or by combined aortic insufficiency and stenosis in New Zealand White rabbits.
Human Myocardium
All procedures involving human myocardium were approved by the ethics committee of the Medical University of Graz (reference No. 20-277 ex08/09) and were performed in accordance with the Declaration of Helsinki. Patient characteristics are summarized in Table I in the online-only Data Supplement.
Cardiomyocyte Isolation
Murine, rabbit, and human ventricular cardiomyocytes were isolated by standard enzymatic dissociation procedures.
Confocal Ca 2+ Imaging of Nucleoplasmic and Cytoplasmic CaTs
Simultaneous imaging of nucleoplasmic and cytoplasmic CaTs occurred in cardiomyocytes loaded with Fluo-4 (Molecular Probes, Leiden, The Netherlands) with a confocal imaging system (Zeiss LSM 510 Meta [Carl Zeiss Group, Oberkochen, Germany] or Olympus FluoView 1000 [Olympus Corp, Tokyo, Japan]) as described previously. 8 Cardiomyocytes were field-stimulated via 2 platinum electrodes. Isoprenaline (30 nmol/L) and angiotensin II (ATII, 100 nmol/L) were used to investigate the effects of β-adrenergic stimulation and inositol 1,4,5-trisphosphate (IP 3 ) signaling, respectively. Cytoplasmic and nucleoplasmic fluorescence signals were transformed into calibrated [Ca 2+ ] by the previously described method. 8 
Imaging of Perinuclear Ca 2+ Stores
Perinuclear Ca 2+ stores were visualized in cardiomyocytes loaded with the low-affinity Ca 2+ indicator mag-fluo-4, AM (Life Technologies, Grand Island, NY), with a confocal imaging system (Zeiss LSM 510 Meta or Olympus FluoView 1000). The optical slice thickness was ≤0.76 μm. Two-dimensional images were collected at a central depth of the nuclei. The longitudinal axis was drawn through the middle of the nuclei, and tubular structures (longer than 1 μm) were counted along the half of the NE, which contained more invaginations. Rapid application of caffeine (20 mmol/L) occurred in the presence of 20 mmol/L 2,3-butanedione monoxime by wash-in of caffeine for 3 seconds. Caffeine experiments were conducted in cardiomyocytes isolated from C57BL/6 mice that did not undergo any surgery.
Immunocytochemistry
Immunocytochemistry was performed as described previously 11 with the following antibodies: mouse monoclonal anti-NPC protein antibody (ab60080; Abcam, Cambridge, United Kingdom), mouse monoclonal anti-SERCA2a and mouse monoclonal anti-RyR (ryanodine receptor) antibody (MA3-919 and MA3-916; Thermo Scientific, Rockford, IL), goat polyclonal anti-IP 3 R2 antibody (NB100-2466; Novus Biologicals, Littleton, CO), rabbit polyclonal anti-P-CaMKII antibody (ab32678; Abcam, Cambridge, United Kingdom), and rabbit polyclonal anti-HDAC4 antibody (sc-11418; Santa Cruz Biotechnology, Santa Cruz, CA). The specificity of the antibodies was confirmed in Western blots.
Electron Microscopy and Immunogold Labeling
Electron microscopic analyses of the NE were performed on human ventricular endocardial trabeculae, prepared as described previously. 12 For immunogold labeling, ultrathin slices of mouse ventricles were stained with primary antibodies as in Immunocytochemistry, except for the rabbit polyclonal anti-SERCA2a antibody (A010-20; Badrilla Ltd, Leeds, United Kingdom). Goat anti-rabbit IgG (10 nm) and rabbit anti-goat IgG (5 nm) gold conjugates were from British BioCell International (BBI, Cardiff, United Kingdom).
Fluorescence Resonance Energy Transfer Imaging
Fluorescence resonance energy transfer (FRET) imaging of CaMKII activation state was performed with the fluorescence resonance energy transfer-based biosensor Camui as described previously. 13
Isolation of Cardiac Nuclei From Human Hearts
A detailed protocol for isolation of cardiac nuclei from human myocardium can be found in the online-only Data Supplement. The final nuclear fraction (N) was tested for expression of Ca 2+ -regulating proteins by standard immunoblot techniques with commercially available antibodies (Immunocytochemistry; anti-Nup62 [610497; BD Transduction Laboratories, Oxford, United Kingdom] and anti-Nkx2.5 [sc-14033; Santa Cruz Biotechnology, Santa Cruz, CA]). The anti-RyR (1093) antibody used was custom-made. 14 For quantification, signals were normalized to GAPDH (H) or Ponceau staining (H and N).
Results

Hypertrophy Versus HF in Mice
Sham-operated mouse hearts showed identical left ventricular (LV) dimensions and systolic function at either 1 or 6 weeks after surgery (not shown). Assessment of LV end-diastolic diameter and LV end-systolic diameter revealed that 1 week after TAC, mice displayed concentric LV hypertrophy, whereas LV dilation was observed 6 weeks after TAC (Table  II and Figure Ia in the online-only Data Supplement). LV systolic function declined progressively, as indicated by ejection fraction reduction of ≈8% 1 week and ≈50% 6 weeks after TAC ( Table II in the online-only Data Supplement). TACinduced hypertrophy was confirmed by increased heart weight normalized to tibia length or body weight (n=5-10; Figure  Ib and Ic in the online-only Data Supplement). Six weeks after TAC, mice developed pulmonary edema as manifested by an elevated ratio of lung weight to tibia length (data not shown). These data indicate that pressure overload-induced myocardial remodeling was associated with an early onset of compensatory hypertrophy and subsequent progression to overt HF.
NE Remodeling in Hypertrophy and HF
In cardiomyocytes from sham-operated mice and rabbits, loading of perinuclear Ca 2+ stores with the low-affinity Ca 2+ indicator mag-fluo-4 revealed an NE and tubular invaginations that traversed the nucleus ( Figure 1A , left). Rapid application of caffeine (20 mmol/L) reversibly abolished mag-fluo-4 fluorescence ( Figure 1C ) both in the NE and in its tubular structures. Fluorescence recovery after depletion was identical in both regions, returning to ≈90% of the precaffeine level (n=7; Figure 1D ). This implies that the NE and its tubular invaginations are functional Ca 2+ stores capable of releasing and reaccumulating Ca 2+ , both in the nuclear periphery and in the regions within the nucleus otherwise remote from the NE.
A significant increase in the density of tubular invaginations, calculated as the number of invaginations per NE circumference in the central depth of the nucleus, was observed during physiological aging in young (2-5 months) shamoperated mice (n=90 nuclei per group; Figure 1B ). In contrast, TAC-operated mice exhibited a progressive decrease in NE http://circ.ahajournals.org/ Downloaded from tubular invagination density 1 and 7 weeks after TAC. Similar reductions were observed in cardiomyocytes from nonfailing versus failing rabbit hearts (n=30 nuclei per group) and from nonfailing versus failing human hearts (n=20 nuclei per group), which suggests a misrelationship between the growth of the nuclei and the NE compartment as a general feature of HF, independent of species and pathogenesis of HF. Average nuclear dimensions and number of NE tubular invaginations per nucleus are summarized in Figure II in the online-only Data Supplement.
To confirm the presence of NE invaginations in cardiac tissue (versus isolated myocytes) and to investigate their detailed structure, electron microscopy imaging of nuclei from sections of human ventricular trabeculae was performed. The observed invaginations were lined by the inner and outer nuclear membranes, interrupted by numerous NPCs (Figure 2A , right, red arrows and inset), and filled with cytoplasm ( Figure 2A , left and middle).
In summary, these data indicate that the NE of cardiomyocytes contains a network of tubular structures (ie, NE invaginations) that undergoes significant changes during hypertrophy and HF. With the progression of cardiac remodeling, the size of nuclei increases, while at the same time, the number of NE invaginations decreases.
Remodeling of Ca 2+ -Regulating Proteins in and Around the Nucleus
We also investigated the (peri)nuclear expression of Ca 2+ release channels, RyR and IP 3 receptor (IP 3 R), NPCs, and SR Ca 2+ -ATPase (SERCA), which could have functional consequences for [Ca 2+ ] nuc and HF progression. Immunostaining of cardiomyocytes confirmed the presence of NPCs in both the NE and its invaginations (n=15; Figure 2B , top). In line with mag-fluo-4 stainings ( Figure 1A ), NPC labeling showed increased nuclear dimensions with reduced number of invaginations in 7-week post-TAC mice and in cardiomyocytes from failing human hearts (quantitative analyses not shown).
In sham-operated mice and in nonfailing human cardiomyocytes, IP 3 R2 was found in a striated pattern throughout the cell, in close proximity to the sarcolemma (most prominent) and on the NE. In HF, accumulation of IP 3 R2 in the perinuclear region was observed (n=15; Figure 2B , middle). Immunogold labeling revealed that IP 3 R2 was localized more prominently on the inner NE surface ( Figure 2D , red arrows), but it was also seen on the outer NE, as well as in the perinuclear region ( Figure 2D , bottom).
A punctate pattern with a striated organization was observed for RyR2, and combined with nuclei staining, it was revealed ( Figure III in the online-only Data Supplement) that RyR2 did not penetrate into the nuclei but rather formed a "cage" around them, as described previously. 15 A large reduction of RyR2 staining in perinuclear regions, in particular in the longitudinal direction, was observed in 7-week post-TAC mice and in cardiomyocytes from failing human hearts (n=15; Figure 2B SERCA2a expression exhibited a characteristic networklike pattern that reflected the SR throughout the cytoplasm. In addition, SERCA2a staining was strongly positive on the NE and its invaginations in sham mouse and nonfailing human cardiomyocytes. Consistent with our earlier observation of blunted invagination density in HF, such structures were absent with SERCA2a immunostaining in either murine or human failing myocytes (n=15; Figure 2B , bottom). Immunogold labeling indicated that SERCA2a was expressed primarily on the outer nuclear membrane (n=11; Figure 2E ; Figure IV in the online-only Data Supplement) and that its expression on the NE was decreased significantly in 7-week post-TAC mice (n=6; Figure 3C , bottom right).
Altered expression levels of Ca 2+ -regulating proteins were confirmed by Western Blot analysis of isolated human cardiac nuclei ( Figure V in the online-only Data Supplement). Nuclear fractions from failing human myocardium exhibited a significant decrease in SERCA2a and RyR2 expression (which was detectable most likely because of remnants of perinuclear regions sticking to the nuclei), whereas IP 3 R2 levels were increased compared with nonfailing hearts.
[Ca 2+ ] cyto and [Ca 2+ ] nuc During Electric Stimulation
Fluo-4 fluorescence signals recorded during electrically stimulated CaTs ( Figure 3A ) were transformed into [Ca 2+ ] nuc and [Ca 2+ ] cyto by our compartment-specific calibration methods ( Figure 3B ). 8 No differences in CaTs were observed between the 2 groups (1 and 7 weeks) of sham-operated mice (data not shown). One week after TAC, diastolic [Ca 2+ ] nuc and [Ca 2+ ] cyto were increased significantly, and they increased further 7 weeks after TAC ( Figure 3C ). The increase of diastolic [Ca 2+ ] nuc was much more pronounced than that of [Ca 2+ ] cyto ( Figure VI in the online-only Data Supplement). Peak systolic [Ca 2+ ] remained unchanged in either compartment (data not shown). Early in hypertrophy, CaTs were slowed and CaT amplitudes were reduced only in the nucleoplasm. At 7 weeks after TAC, similar changes of CaTs also occurred in the cytoplasm ( Figure 3D and 3E).
The NE invaginations and SERCA2/RyR2 distribution suggest the following working model of nuclear CaTs. The rise in [Ca 2+ ] nuc is driven mainly by an RyR2-dependent rise in perinuclear [Ca 2+ ] cyto , and the primarily cytosolic facing SERCA2 distribution suggests that Ca 2+ may largely have to diffuse out of the nucleus to be pumped back into the NE and SR. These aspects would slow the rise and fall of nuclear versus cytosolic CaTs (as observed) and could be exacerbated by the reduction in invaginations during the progression to HF. We measured this diffusional delay during development of HF in the TAC mice in the present study by measuring CaTs at the surface and center of both the nucleus and cytosol (Figure 3F through 3J; Figure VII in the online-only Data Supplement). Kinetics of cytosolic CaTs were spatially uniform and unaltered 1 week after TAC (n=10; Figure VII in the online-only Data Supplement). However, at 7 weeks after TAC, there was some slowing of the central CaT versus the subsarcolemmal CaT ( Figure VII in the online-only Data Supplement), presumably caused by the reported reduction in T-tubular density that occurs in HF. 16 In contrast, nuclear CaT propagation velocity (difference in time to peak between subnucleolemmal Figure 3H ). This observation might be particularly relevant at high stimulation frequencies, when diastolic [Ca 2+ ] nuc is more affected than [Ca 2+ ] cyto because of its slower kinetics. 8 In the rabbit HF model, we also observed elevated diastolic [Ca 2+ ] nuc and slowed kinetics of [Ca 2+ ] nuc rise ( Figure VIII in the online-only Data Supplement).
Importantly, in human myocytes (both for moderate and severe HF), we saw quite similar effects as in the 1-and 7-week post-TAC mice (Figure 4 ). Although a low number of moderately failing hearts is a limitation of the study, the present results suggest that early alterations in CaTs that occur selectively in the nucleus might be clinically relevant for the progression of cardiac remodeling in HF patients.
Correlation of NE Invaginations With Nuclear CaT Kinetics
In mouse and rabbit cardiomyocytes, we simultaneously quantified NE invaginations (with mag-fluo-4) and spatiotemporal aspects of cytoplasmic and nucleoplasmic CaTs (with rhod-2). Figure 5A shows that nuclear CaT propagation was slowed in cardiomyocytes with lower NE invagination density. Correlation analysis indicated a strong inverse correlation between the density of NE invaginations and Ca 2+ propagation to and from the nucleus (time from peak [Ca 2+ ] to 50% decline [DT 50 ]) in both sham and HF conditions ( Figure 5B ). This means that there is indeed a functional link between NE structure and nuclear CaTs kinetics. Figure 6A and 6B shows recordings in which stimulation frequency was gradually increased from 0.5 to 5 Hz (mouse cells) or from 0.2 to 1 Hz (rabbit cells). In all 3 groups of mice, diastolic [Ca 2+ ] in the nucleus and cytoplasm rose with an increase in stimulation frequency ( 2+ ] resulted in a progressive decline in CaT amplitude with faster stimulation rates. The reduction of CaT amplitude started at a lower frequency in the nucleoplasmic versus cytoplasmic compartment. Similar changes were observed in cardiomyocytes from nonfailing versus failing rabbit hearts ( Figure 6B) .
Frequency-Dependent Changes of Nucleoplasmic CaTs
In further experiments, we investigated whether β-adrenergic stimulation could diminish or prevent the disproportionate rise in [Ca 2+ ] nuc in hypertrophied and failing cardiomyocytes to increased stimulation frequencies ( Figure 6A, right) . β-Adrenergic stimulation greatly accelerates CaT decay and thereby might blunt the frequency-dependent increases in diastolic [Ca 2+ ]. 17 Application of isoprenaline (30 nmol/L) resulted in a robust increase of both nucleoplasmic and cytoplasmic CaTs in control cardiomyocytes; however, the preferential rise in diastolic [Ca 2+ ] nuc was still observed and again was more pronounced as HF progressed (1 versus 7 weeks after TAC). Average data and statistical analysis related to Figure 6A are summarized in Table III in the online-only Data  Supplement. Collectively, these data revealed 3 important points: (1) The frequency-dependent increase in diastolic [Ca 2+ ] nuc was much larger than the increase in diastolic [Ca 2+ ] cyto ; (2) it persisted with β-adrenergic stimulation; and (3) this effect was even more pronounced in failing myocytes.
Frequency-Dependent Activation of Nuclear CaMKII and Nuclear Export of HDAC
In cardiomyocytes from sham-operated mice stimulated at low frequency (0.5 Hz), there was only weak staining of the autonomously active form of CaMKII, phospho-CaMKII, in the cytoplasm and within the nucleus ( Figure 6C) under the same pacing conditions, with much larger increases in the nucleus (particularly in the NE), especially and markedly in HF (n=25; Figure 6C ). The phospho-CaMKII signals were prevented by preincubation with KN-93 (1 μmol/L), which confirmed the functional basis of the observed signals.
We also expressed the fluorescence resonance energy transfer-based biosensor CaMKII activity reporter Camui in control and HF rabbit cardiomyocytes. Camui displayed similar cellular distribution as the endogenous phospho-CaMKII detected by immunocytochemistry, consistent with known CaMKII localization. Camui signals indicated significantly higher CaMKII activation in the nucleus and cytoplasm of failing cardiomyocytes at rest (n≥32; Figure 6D ).
HDAC4 is a transcriptional regulator that is a downstream effector of CaMKII in the nucleus. 10 That is, CaMKII binds to and phosphorylates HDAC4 to drive HDAC4 nuclear export and derepression of hypertrophic transcription. We found that in HF versus control myocytes, HDAC4 was less nuclear at low frequency stimulation and was more readily driven out by increasing the pacing frequency (n≥20; Figure 6E ), as expected given the frequency-dependent increase in nuclear CaTs and CaMKII activation ( Figure 6A through 6C ). Figure 7A shows line-scan images of CaTs from electrically stimulated cardiomyocytes in the absence or presence of ATII, which is known to cause IP 3 production in cardiomyocytes. 19 In sham-operated mice, application of ATII increased diastolic [Ca 2+ ] in both the cytoplasm and nucleus (n=15; Figure 7B and 7C). The increase in [Ca 2+ ] nuc was much larger than the increase in diastolic [Ca 2+ ] cyto , and this effect was augmented in 7-week post-TAC cardiomyocytes. Large increases in diastolic [Ca 2+ ] led to significant increases in systolic [Ca 2+ ] in both compartments ( Figure 7D ), whereas CaT amplitude remained unaltered. ATII raised systolic [Ca 2+ ] cyto to similar levels in sham versus TAC cardiomyocytes, whereas on ATII application, systolic [Ca 2+ ] nuc was significantly higher in 7-week post-TAC cardiomyocytes than in controls. Application of 2-aminoethoxydiphenyl borate (3 μmol/L) completely blocked the effect of ATII (data not shown), consistent with the ATII effects being IP 3 mediated.
Role of IP 3 in Regulation of Nucleoplasmic CaTs
Discussion
The present study is the first to provide direct, compelling evidence for structural and functional changes of the NE and nucleoplasmic Ca 2+ handling during cardiac remodeling and HF in mouse and rabbit models of pressure overload and in human hearts. The progressive decrease in NE invagination density and changes in the Ca 2+ -regulatory protein expression patterns (schematically summarized in Figure 8 ) were associated with alterations of nucleoplasmic [Ca 2+ ] handling and consequent activation of gene transcription via the nuclear CaMKII-HDAC4 axis in electrically stimulated The NE of numerous cell types (including cardiomyocytes) contains invaginations that include deep, branching tubular structures (for review, see Malhas et al 9 ). As caffeine experiments ( Figure 1C ) demonstrated, the NE and its invaginations represent functional Ca 2+ stores capable of releasing and reaccumulating Ca 2+ . It is tempting to speculate that similar to T-tubular sarcolemmal invaginations, which are critical for coordinated Ca 2+ cycling throughout the myocyte, nuclear tubular invaginations may be critical for minute control of nucleoplasmic Ca 2+ release and removal. Recent work suggested that the NE invaginations might be an artifact caused by NE folding attributable to the shorter sarcomere length in isolated cells. 15 However, we also observed NE invaginations in multicellular cardiac tissue (Figure 2A) . Furthermore, the fact that sarcomeres in cardiomyocytes rhythmically shorten and lengthen during the contraction-relaxation cycle suggests that NE invaginations might change in number and depth in the beating heart.
There are several important consequences of the NE invaginations penetrating into the nucleus. In general, they facilitate intranuclear regulation of ions and transcription factors that travel between cytoplasm and nucleoplasm by decreasing the diffusion delay and by increasing membrane surface area, which may be critical for the regulation of gene transcription. The presence of NPCs on the NE invaginations ensures effective nucleoplasmic-cytoplasmic ion diffusion and cargo transport in regions that would otherwise be remote from the nuclear periphery. Expression of SERCA pumps on the invaginations enables Ca 2+ removal from deep within the nucleus, but because most SERCA2 pumps face the cytoplasmic side, their position with respect to nuclear pores may be important in shaping nucleoplasmic CaT kinetics.
Our working hypothesis, based on NE invaginations and NPC, SERCA2, and RyR2 distribution is the following (Figure 8) : Normally, the rise in [Ca 2+ ] nuc is driven mainly by the RyR2-dependent rise in [Ca 2+ ] cyto that occurs during excitation-contraction coupling, and Ca 2+ diffusion via NPCs (including invaginations) is the cause of slower rise times and peak [Ca 2+ ] nuc . NE SERCA2 mainly faces the cytoplasm (where there is also much more SERCA on SR), which indicates that most Ca 2+ may have to diffuse out of the nucleus to be pumped back into the NE and SR (which would account for the much slower [Ca 2+ ] nuc decline). The loss of NE invaginations which occurs early in HF (in mouse, rabbit, and human) would reduce NPC and SERCA within the nuclear core, exacerbate the slowing of nuclear CaTs, and elevate diastolic [Ca 2+ ] nuc , especially at higher heart rates. Indeed, we directly measured all those effects here, even in the presence of β-adrenergic stimulation. The overall decrease in SERCA functional expression in HF slowed [Ca 2+ ] cyto decline, which further increased diastolic [Ca 2+ ] nuc in HF. The profound increase in diastolic [Ca 2+ ] nuc and consequent higher CaMKII activation level that we observed in myocytes from the early TAC group at higher pacing frequencies may be causally involved in the remodeling processes that lead to HF, in particular when one considers the often elevated heart rates of patients with HF. Indeed, the SHIFT (Systolic Heart Failure Treatment With the I f Inhibitor Ivabradine) trial data demonstrated a beneficial effect of lowering the heart rate by ivabradine in patients with advanced systolic heart failure, both in terms of attenuated LV remodeling 20 and less frequent hospitalizations. 21 The simple working hypothesis above becomes complicated somewhat by the IP 3 R localization that was preferentially (but not exclusively) facing the nucleoplasm. G q -coupled receptors (α-adrenergic, endothelin, and ATII receptors) that induce IP 3 production may be more activated during HF progression. 22, 23 Moreover, elevated [Ca 2+ ] nuc would enhance the IP 3 sensitivity of IP 3 Rs 24 and could well synergize with the other factors that elevate [Ca 2+ ] nuc in HF and at high heart rates, as we have shown for ATII. Indeed, IP 3 R-mediated Ca 2+ release from the NE can elevate local [Ca 2+ ] nuc independently from [Ca 2+ ] cyto.
2,10
This pathway may be central in cardiac excitation-transcription coupling, 10, 25 and hence, increased IP 3 R expression was proposed to be important during hypertrophy and HF. 10, 26, 27 In line with this notion, we observed increased perinuclear IP 3 R expression and higher diastolic [Ca 2+ ] nuc versus [Ca 2+ ] cyto in HF cardiomyocytes treated with ATII.
Perinuclear RyR expression was reduced here in HF, which would further slow the rise in [Ca 2+ ] nuc but could also shift perinuclear Ca 2+ signaling in favor of IP 3 R-mediated Ca 2+ release during the progression from hypertrophy to HF. Nuclear factor of activated T-cells (NFAT) is a mediator of calcineurindependent nuclear signaling, and ATII and endothelin 1 could activate this system in adult ventricular cardiomyocytes. 28 It was speculated that the perinuclear region could represent a local reserve of NFAT that is poised for shuttling in and out of the nucleus when local [Ca 2+ ] is elevated via IP 3 -mediated Ca 2+ release. 28 Furthermore, nuclear calcineurin is increased in human HF 29 and required for full transcriptional effects of NFAT. 30 Similarly, in adult ventricular myocytes, α-adrenergic receptor activation selectively increased nuclear CaMKIIδ phosphorylation (without altering SR-associated CaMKII), an effect attributed to Ca 2+ mobilized through nuclear IP 3sensitive stores. 31 Accumulation of IP 3 Rs in this region in cardiomyocytes from failing hearts would support the idea of enhanced NFAT and CaMKII signaling and activation of a hypertrophic gene program.
During the past 2 decades, great advances have been made in understanding alterations in cytoplasmic ion homeostasis in cardiomyocytes during the development of hypertrophy and HF. Here, we show for the first time how nucleoplasmic Ca 2+ homeostasis is altered during this hypertrophy-HF process. We provide evidence for structural and functional alterations of the nucleus and nuclear Ca 2+ signaling as remodeling progresses. Importantly, the changes were observed not only in animal models of hypertrophy and HF but also in human HF. The present results implicate [Ca 2+ ] nuc as an important determinant of cardiac remodeling that may contribute to the development and progression of hypertrophy and HF. Normalization of nucleoplasmic Ca 2+ regulation may therefore be a novel therapeutic approach to prevent adverse cardiac remodeling. 
CLINICAL PERSPECTIVE
Hypertrophy and heart failure are severe and widespread cardiac diseases associated with increased morbidity and mortality. Understanding the underlying cellular mechanisms is crucial for developing new treatment strategies and thereby improving prognosis. Numerous studies have identified impaired cytoplasmic Ca 2+ handling of cardiomyocytes as underlying contractile failure in hypertrophy and heart failure. Here, we show for the first time how nucleoplasmic Ca 2+ homeostasis is altered during this hypertrophy-heart failure transition. We provide compelling evidence that nuclear envelope structure, its molecular composition, and nucleoplasmic Ca 2+ transients undergo significant changes as remodeling progresses. These nuclear changes precede the changes in cytoplasmic Ca 2+ dysregulation, thus suggesting that altered nucleoplasmic [Ca 2+ ] is an early event during remodeling and may contribute to the development and progression of cardiac hypertrophy and heart failure. Importantly, the changes were observed not only in animal models of hypertrophy and HF but also in nonfailing, moderately failing, and end-stage failing human hearts, hence strengthening their general applicability and clinical relevance. In conclusion, the present work presents a new paradigm for cardiac hypertrophy and failure, in which early remodeling of nuclear calcium homeostasis is an important factor for the development and progression of this common and severe cardiac disease. Normalization of impaired nucleoplasmic Ca 2+ regulation may therefore be a novel therapeutic approach for the prevention of adverse cardiac remodeling.
Supplemental Material
Materials and Methods
Cell Preparation
Murine myocyte isolation
The procedure was approved by the local Animal Care and Use Committees according to the Guide for the Care and Use of Laboratory Animals prepared by the U.S. National Academy of Sciences (National Institutes of Health publication No. 85-23, revised 1996). Adult ventricular myocytes were isolated by a liberase-based Langendorff perfusion protocol as described in detail previously 1 . All in vitro experiments were conducted at room temperature (22-24°C) .
Human myocyte isolation
The procedure was approved by the Ethical Committee of the Medical University of Graz (ref.
No. 20-277 ex08/09) and was carried out in accordance with the Declaration of Helsinki.
Myocardial samples were obtained from the explanted failing hearts at the time of transplantation (N=5) and from unused donor hearts (N=8). Heart function was evaluated by transthoracic echocardiography and divided into three groups: non-failing (EF≥55%), moderately failing (55%>EF>35%) and severely failing (EF≤35%). In severely failing group, only patients with dilated cardiomyopathy (DCM) were included in this study. Patient characteristics are summarized in Table S1 .
The procedure for cell isolation was modified after Sipido et al. 2 . Immediately following the resection, hearts were perfused with Custodiol ® cardioplegic solution in the operating room at the time of surgery. Hearts were kept at 4C in Custodiol ® solution supplemented with 2,3butanedione-monoxime (BDM). A wedge of the left ventricular wall with its perfusing coronary artery was carefully excised, the artery was cannulated and perfused with Tyrode's solution (in mM: 130 NaCl, 5.4 KCl, 1.2 MgSO 4 , 1.8 CaCl 2 , 20 HEPES, 10 taurine, 12.5 glucose, 2 pyruvate and 1 Na-L-lactate; pH 7.2 with NaOH). After cannulation the tissue wedge was perfused at 37C with a Ca 2+ -free Tyrode's solution for 10 min followed by enzyme perfusion for 25 min (liberase 0.15 mg/ml, trypsin 0.056 mg/ml, in 0.05 mM CaCl 2 Tyrode's solution). The tissue was sectioned in slices of 5-7 mm and minced in 0.1 mM CaCl 2 Tyrode's solution. The preparation was filtered and a small part of the cell yield was fixed for immunocytochemistry. In the remainder the solution was stepwise replaced by Tyrode's solution containing 1.8 mM CaCl 2 . Ca 2+ -tolerant cell yield was 5-20% and it was used for CaT recordings.
Rabbit myocyte isolation
Isolation protocol was performed in accordance with the Guide for the Care and Use of Laboratory Animals and approved by the University of California, Davis Institutional Animal Care and Use Committee. Adult rabbit ventricular cardiomyocytes were isolated from New Zealand white rabbits by standard enzymatic dissociation as described previously 3 . Eight to eleven weeks old C57BL/6 wild-type mice of 21±1 g (females) and 24±1 g (males) body weight underwent transverse aortic constriction (TAC) surgery as described previously 4 . An ageand weight-matched group of mice underwent sham procedure consisting of aortic exposure without ligation and served as control. Ventricular cardiomyocytes were isolated 1 and 7 weeks after TAC/sham. One and six weeks after sham/TAC intervention, transthoracic echocardiography was performed 5 and left ventricular fractional shortening (FS) and left ventricular mass (LV mass ) was calculated as previously described 4 .
Animal disease models
Mouse hypertrophy and heart failure model
Rabbit heart failure model
HF was induced in New Zealand White rabbits by combined aortic insufficiency and stenosis as previously described 3 . HF progression was assessed by 2D echocardiography and rabbits were studied ~12 months later, when end-systolic dimension exceeded 12 mm 3 . All protocols followed the Guide for the Care and Use of Laboratory Animals and were approved by the University of California, Davis Institutional Animal Care and Use Committee.
Confocal Ca 2+ imaging of nucleoplasmic and cytoplasmic CaTs
Cells were loaded with the Ca 2+ -sensitive fluorescent dye Fluo-4 (Molecular Probes, Leiden, The Netherlands) as described previously 6 For quantification of nucleoplasmic vs. cytoplasmic CaTs cells were field-stimulated via two platinum electrodes at 1 Hz (mouse) or 0.5 Hz (rabbit and human). To measure the frequencydependent changes in CaTs, stimulation frequency was gradually increased from 0.5 Hz to 5 Hz (mouse) or from 0.2 Hz to 1.5 Hz (rabbit). Isoprenaline (30 nM) and angiotensin II (ATII, 100 nM) were used to investigate the effects of β-adrenergic stimulation and IP 3 signaling, respectively. Cytoplasmic and nucleoplasmic fluorescent signals were transformed into calibrated [Ca 2+ ] using the previously described method 6 .
Isolation of cardiac nuclei from human hearts
Ventricular myocardium from human hearts (N=12) was homogenized (H), filtered, diluted with water (3:1), and layered onto 1.5 volumes of buffer A (in mM: Hepes (pH 7.2) 10; sucrose 320; MgCl 2 3; disodium pyrophosphate 25; EGTA 5; PMSF 1; leupeptin 0.001; pepstatin 0.001; DTT 1). Following a first centrifugation at 700g for 10 min at 4°C, the pellet (P1) containing the nuclei was suspended in hypotonic buffer A1 (buffer A without disodium pyrophosphate and with only 2.4 mM sucrose). The suspension was centrifuged at 50.000 g for 90 min at 4°C. Afterwards, the pellet (P2) containing the nuclei was suspended in nucleus storage buffer (in mM: Hepes (pH 7.6) 50; sucrose 320; magnesium acetate 5; Na 3 EDTA 0.1; EGTA 1; PMSF 0.1; leupeptin 0.001; pepstatin 0.001; DTT 1). Finally, this suspension was spun down at 800g for 10 min, and the final nuclear pellet (N) was suspended in 0.1 ml nucleus storage buffer. Immunoblot analysis of the various fractions (H = whole tissue homogenate; S1 and S2 = supernatant after first and second centrifugation step, respectively; P1 and P2 = pellet after first and second centrifugation step, respectively; N = final purified nuclear fraction) revealed enrichment of nuclear markers (Nup62, Nkx2.5) in P1, P2, and N, and the absence of the cytoplasmic marker GAPDH in these fractions ( Figure S4a ). In addition, microscopic analysis showed intact isolated nuclei in the final nuclear fraction ( Figure S4b) .
The final nuclear fraction (N) was tested for expression of Ca 2+ -regulating proteins ( Figure S4c) using standard immunoblot techniques with commercially available antibodies (see section Immunocytochemistry; anti-Nup62 (610497, BD Transduction Laboratories, Oxford, UK) and anti-Nkx2.5 (sc-14033, Santa Cruz Biotechnology, Santa Cruz, CA, USA)). The anti-RyR (1093) antibody used was custom-made 7 . For quantification, signals were normalized to GAPDH (H) or Ponceau staining (H and N).
Electron microscopy and immunogold labeling
Electron microscopic analyses of the NE were performed on human ventricular endocardial trabeculae, prepared as previously described 8 . The samples were fixed at 4°C over night in 0.1 M sodium cacodylate buffer, pH 7.4, containing 2% glutaraldehyde and 2.5% formaldehyde. The samples were post-fixed for 2h at room temperature in the same buffer additionally containing 2% osmium tetroxide, rinsed and dehydrated in a series of graded ethanol solutions. Using propylene oxide as an intermedium, the samples were embedded in TAAB epoxy resin (TAAB, Aldermaston, UK). 60 nm thick sections were cut on a Leica UCT ultramicrotome (Leica Mikrosysteme Handelsges.m.b.H., Vienna, Austria). The sections were stained in lead citrate and uranyl acetate using a Leica EM AC20 contrasting instrument, and then visualized using a FEI Tecnai G²20 transmission electron microscope (FEI, Eindhoven, Netherlands), as described previously 9 .
For immunogold labeling, mouse hearts were quickly excised and perfused with PBS. Ventricles were placed in fixing solution (0.1% glutaraldehyde, 2% paraformaldehyde, in 0.1 % sodiumphosphate buffer, pH 7.4) and sliced with a razor blade in cubes sized 1-2 mm 3 . After 1-3h, tissue pieces were rinsed and dehydrated in a series of graded ethanol solutions. Samples were incubated in a mixture of LR White Embedding Medium and 80% ethanol (1:1) for 1h and twice in pure LR White for 1h. Resin was allowed to polymerize for 24h at 50ºC. Ultrathin sections were cut and mounted on nickel grids. Grids were washed in phosphate buffered gelatine (PBG) solution (0.8% BSA in PBS, 0.1% fish gelatine, 0.1M glycin) and incubated in blocking solution (5% normal goat (for goat anti-rabbit IgG gold conjugate) or normal rabbit (for rabbit anti-goat IgG gold conjugate) serum in PBG solution containing 0.05% Tween20). Grids were incubated for 2h with primary anti-IP 3 R and anti-RyR antibodies as mentioned in Immunocytochemistry section, and a rabbit polyclonal anti-SERCA2a antibody (A010-20, Badrilla, Leeds, UK)). After rinsing, sections were incubated with goat anti-rabbit IgG (10 nm) or rabbit anti-goat IgG (5 nm) gold conjugates from British BioCell International (BBI, Cardiff, UK). Slices were finally washed with PBS and distilled water and left to air dry. Isotype controls with identical staining procedures, but replacing the primary antibodies with negative controls (Rabbit IgG Ab-1, NC-100-P1, Neo Markers, Fremont, CA, USA and Goat IgG-UNLB, 0109-01, Southern Biotech, Birmingham, AL, USA) showed no labeling. Additional negative controls, replacing the primary antibodies with PBS were performed on every experimental day.
Imaging of the sections was performed as described above. For each nuclus, the entire 2D cross section of nuclear envelope was visualized by merging consecutive high magnification images (see Figure S8 ). For quantitative analyses of SERCA2a staining, the number of gold particles within a narrow band at distances of <50 nm from the midline between the inner and the outer nuclear membrane was assessed.
